Loading…
Ensuring Equal Access to Treatments Act of 2014
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
29pct
1d open
vs 5,821 other HR bills in the 113th — cohort avg 49d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (9)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2015 · first_quarter · Medicare/Medicaid
S. 31: Medicare Prescription Drug Price Negotiation Act of 2015 - Provisions related to Secretary negotiation authority in Part D program S. 141: Protecting Seniors' Access to Medicare Act of 2015 - Provisions related to Independent Payment Advisory Board (IPAB) repeal S. 648: Medicare Formulary Improvement Act - Provisions related to codification of six protected classes in Part D program S. 861: Preventing and Reducing Improper Medicare and Medicaid Expenditures Act of 2014 -Provisions related to anti-fraud proposals affecting federal programs H.R. 2: Medicare Access and CHIP Reauthorization Act of 2015 - Provisions related to Sustainable Growth Rate (SGR) reform and other Medicare, Medicaid, and CHIP amendments H.R. 1021: Protecting the Integrity of Medicare Act of 2015 - Provisions related to Part D lock-in program and other Medicare anti-fraud provisions H.R. 1190: Protecting Seniors' Access to Medicare Act of 2015 - Provisions related to IPAB repeal H.R. 1470: SGR Repeal and Medicare Provider Payment Modernization Act of 2015 - Provisions related to SGR reform and other Medicare, Medicaid, and CHIP amendments H.R. 3796: Comprehensive Care Payment Innovation Act - Provisions related to ensuring access to innovative treatments in delivery reform model (113th Congress) H.R. 4857: Ensuring Access to Treatment Act (discussion draft) - Provisions related to changes to Part B hospital outpatient drug payment policy (113th Congress) H.R. 5183: Value Based Insurance Design for Better Care Act of 2014 - Provisions related to changes to the Medicare Advantage Program (113th Congress) Hospital Improvements for Payment Act (discussion draft) - Provisions related to Medicare Parts A and B reform Cancer Care Payment Reform Act (discussion draft): Provisions related to oncology medical home demonstration Department of Health and Human Services (HHS) delivery system reform issues and regulatory barriers to innovation Medicare Part B Average Sales Price (ASP) issues Part D lock-in related legislation Medicare exclusion issues Medicare Part D rebates issues
Client expense: $5,440,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
2014 · fourth_quarter · Health Issues
H.R. 4857, Ensuring Equal Access to Treatments Act of 2014; S. 2980, Ensuring Equal Access to Treatments Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Medicare/Medicaid
Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152); Issues related to the Medicare hospital outpatient issues (H.R. 4857, S. 2980); Developing an Innovative Strategy for Antimicrobial Resistance Microorganisms Act of 2014 (DISARM) (H.R. 4187)
Client expense: $440,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Medicare/Medicaid
Advocacy in support of Medicare coverage for outpatient cancer drugs, including H.R. 4857, Ensuring Equal Access to Treatments Act of 2014
Client expense: Not reported · Firm income: $90,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Medicare/Medicaid
General reimbursement issues H.R. 4857/S.2980 Ensuring Equal Access to Treatments Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Medicare/Medicaid
Medicare physician payment; Medicare coverage; Medicare hospital payment; physician and hospital quality; medical liability reform; electronic health record incentive program; clinical data registries; graduate medical education; health care quality; medical imaging and prior authorization; in-office ancillary services exception. HR 2914, Promoting Integrity in Medicare Act; SGR Repeal and Beneficiary Access Improvement Act; HR 4015/S 2000, SGR Repeal and Medicare Provider Payment Modernization Act; S 2501, Hospital Readmission Accuracy and Accountability Act; S 1932/HR 3890, Better Care, Lower Cost Act; Facilitating Participation in Clinical Data Registries Act; IMPACT Act; S 2552, Medicare Advantage Participant Bill of Rights Act; HR 4282, CARE Act; HR 4930, Advancing Care for Exceptional Kids Act; S 961/HR 36, Health Care Safety Net Enhancement Act; HR 5215, to provide for recommendations for the development and use of clinical data registries; HR 5481, FLEX-IT Act; HR 4188, Establishing Beneficiary Equity in the Hospital Readmission Program Act; HR 4857, Ensuring Equal Access to Treatments Act; S 1758, Quality Data, Quality Healthcare Act; HR 4418, Expanding the Availability of Medicare Data Act; Hospital Improvements for Payment (HIP) Act of 2014; Protecting Integrity in Medicare Act of 2014 (PIMA); HR 647, ABLE Act; S 2461/HR 5364, CHIP Extension and Improvement Act of 2014.
Client expense: $410,000 · Firm income: Not reported
2014 · fourth_quarter · Health Issues
H.R.4857, Ensuring Equal Access to Treatments Act of 2014; H.R. 3230, Veterans Access, Accountability Act of 2014, provisions related to prescription drug services.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Health Issues
Implementation of Drug Quality and Security Act SGR legislation 21st Century Cures Initiative H.R.4857 Ensuring Equal Access to Treatments Act of 2014H.R.2869 - Medicare Patient Access to Cancer Treatment Act of 2013 H.R.4857 - Ensuring Equal Access to Treatments Act of 2014
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Medicare/Medicaid
Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to the Medicare hospital outpatient issues (H.R.4857). Developing an Innovative Strategy for Antimicrobial Resistance Microorganisms Act of 2014 (DISARM) (H.R. 4187)
Client expense: $400,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Medicare/Medicaid
Advocacy in support of Medicare coverage for outpatient cancer drugs, including H.R. 4857, Ensuring Equal Access to Treatments Act of 2014
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Medicare/Medicaid
Medicare physician payment; clinical data registries; graduate medical education; health care quality; medical imaging and prior authorization; in-office ancillary services exception; HR 2914, Promoting Integrity in Medicare Act; SGR Repeal and Beneficiary Access Improvement Act of 2014; HR 4015/S 2000, SGR Repeal and Medicare Provider Payment Modernization Act; S 2501, Hospital Readmission Accuracy and Accountability Act; S 1932/HR 3890, Better Care, Lower Cost Act; IMPACT Act;S 2552, Medicare Advantage Participant Bill of Rights Act; HR 4282, CARE Act; HR 4930, Advancing Care for Exceptional Kids Act; S 961/HR 36, Health Care Safety Net Enhancement Act; Facilitating Participation in Clinical Data Registries Act; HR 4188, Establishing Beneficiary Equity in the Hospital Readmission Program Act; HR 4857, Ensuring Equal Access to Treatments Act; S 1758, Quality Data, Quality Healthcare Act; HR 4418, Expanding the Availability of Medicare Data Act.
Client expense: $850,000 · Firm income: Not reported
2014 · third_quarter · Health Issues
H.R. 4857, Ensuring Equal Access to Treatments Act of 2014; H.R. 3230, Veterans Access, Choice and Accountability Act of 2014, provisions related to prescription drug services.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
Implementation of Drug Quality and Security Act SGR legislation 21st Century Cures Initiative H.R.4857 Ensuring Equal Access to Treatments Act of 2014H.R.2869 - Medicare Patient Access to Cancer Treatment Act of 2013 H.R.4857 - Ensuring Equal Access to Treatments Act of 2014
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Medicare/Medicaid
Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to the Medicare hospital outpatient issues (H.R.4857). Developing an Innovative Strategy for Antimicrobial Resistance Microorganisms Act of 2014 (DISARM) (H.R. 4187)
Client expense: $470,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Medicare/Medicaid
Advocacy in support of Medicare coverage for outpatient cancer drugs, including H.R. 4857, Ensuring Equal Access to Treatments Act of 2014
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Health Issues
Health Equity and Accountability Act reintroduction, aspirin as primary prevention of cardiovascular events, Medicare packaged payment policy (H.R. 4857), biosimiliars
Client expense: Not reported · Firm income: $10,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES
2014 · second_quarter · Health Issues
H.R. 4187, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2014; H.R. 4857, Ensuring Equal Access to Treatments Act of 2014
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Health Issues
Implementation of Drug Quality and Security Act SGR legislation 21st Century Cures Initiative H.R.4857 Ensuring Equal Access to Treatments Act of 2014
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
| Republican |
| TX |
| Bill Pascrell, Jr. | Democratic | NJ |
| Bradley Scott Schneider | Democratic | IL |
| Charles W. Boustany Jr. | Republican | LA |
| Doris O. Matsui | Democratic | CA |
| Erik Paulsen | Republican | MN |
| Jim McDermott | Democratic | WA |
| Joseph Crowley | Democratic | NY |
| Linda T. Sánchez | Democratic | CA |
| Lois Capps | Democratic | CA |
| Mark Takano | Democratic | CA |
| Marsha Blackburn | Republican | TN |
| Mike Kelly | Republican | PA |
| Mike Rogers | Republican | MI |
| Pete Olson | Republican | TX |
| Peter J. Roskam | Republican | IL |
| Richard E. Neal | Democratic | MA |
| Ron Kind | Democratic | WI |
| Tim Griffin | Republican | AR |
| Todd Young | Republican | IN |
| Zoe Lofgren | Democratic | CA |
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE